Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PFIZER, INC.

(PFE)
  Report
Delayed Nyse  -  04:03 2022-09-26 pm EDT
43.83 USD   -0.57%
01:43pPfizer seeks to expand omicron booster to 5- to 11-year-olds
AQ
01:01pIn 4 Weeks Meet Pfizer, AstraZeneca, DiME & Many More at the Biosensors for Medical Wearables Conference
AQ
12:10pWhat Is DE&I? Why It Matters?
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer Says Pneumococcal Disease Vaccine Has Potential to Provide Broadest Serotype Coverage Following Phase 3 Study

08/12/2022 | 07:33am EDT


© MT Newswires 2022
All news about PFIZER, INC.
01:43pPfizer seeks to expand omicron booster to 5- to 11-year-olds
AQ
01:01pIn 4 Weeks Meet Pfizer, AstraZeneca, DiME & Many More at the Biosensors for Medical Wea..
AQ
12:10pWhat Is DE&I? Why It Matters?
AQ
09:30aCapitulation ahead?
MS
09:09aSector Update: Health Care Stocks Mixed Premarket Monday
MT
08:42aPfizer, BioNTech Seek FDA Approval for COVID-19 Vaccine Targeting Omicron Subvariants i..
MT
08:33aTrending : Pfizer, BioNTech Seek OK for Covid-19 Booster in Kids
DJ
07:31aPfizer, BioNTech Submit US FDA Emergency Use Application For Omicron-Adapted Vaccine Fo..
MT
07:20aPfizer/BioNTech seek FDA nod for new COVID boosters for children
RE
07:05aPfizer, BioNTech File FDA Application for Emergency Use Authorization of Omicron-Specif..
MT
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2022 102 B - -
Net income 2022 32 739 M - -
Net cash 2022 10 262 M - -
P/E ratio 2022 7,78x
Yield 2022 3,68%
Capitalization 247 B 247 B -
EV / Sales 2022 2,33x
EV / Sales 2023 2,90x
Nbr of Employees 79 000
Free-Float 59,0%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 44,08 $
Average target price 55,75 $
Spread / Average Target 26,5%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
David M. Denton Chief Financial Officer & Executive Vice President
Mikael Dolsten Executive VP, President-Research & Development
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.-25.35%247 392
JOHNSON & JOHNSON-2.54%438 337
ELI LILLY AND COMPANY12.76%295 941
ROCHE HOLDING AG-18.41%259 291
ABBVIE INC.5.66%252 944
NOVO NORDISK A/S1.95%221 838